(19)
(11) EP 2 498 818 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.03.2018 Bulletin 2018/12

(45) Mention of the grant of the patent:
14.02.2018 Bulletin 2018/07

(21) Application number: 10828973.7

(22) Date of filing: 02.11.2010
(51) International Patent Classification (IPC): 
A61K 47/04(2006.01)
A61K 47/38(2006.01)
A61K 9/20(2006.01)
A61K 31/375(2006.01)
 A61K 47/02(2006.01)
A61K 47/30(2006.01)
A61K 9/16(2006.01)
(86) International application number:
PCT/US2010/055102
(87) International publication number:
WO 2011/056785 (12.05.2011 Gazette 2011/19)

(54)

MICROCRYSTALLINE CELLULOSE AND CALCIUM PHOSPHATE COMPOSITIONS USEFUL AS PHARMACEUTICAL EXCIPIENTS

MIKROKRISTALLINE ZELLULOSE UND CALCIUMPHOSPHATZUSAMMENSETZUNGEN, DIE ALS PHARMAZEUTISCHE HILFSSTOFFE NÜTZLICH SIND

COMPOSITIONS DE CELLULOSE MICROCRISTALLINE ET DE PHOSPHATE DE CALCIUM UTILES EN TANT QU'EXCIPIENTS PHARMACEUTIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 05.11.2009 US 258390 P

(43) Date of publication of application:
19.09.2012 Bulletin 2012/38

(73) Proprietor: FMC Corporation
Philadelphia, PA 19104 (US)

(72) Inventors:
  • THOORENS, Gregory
    B-1780 Wemmel (BE)
  • LECLERCQ, Bruno
    B-1190 Brussels (BE)
  • RUSZKAY, Thomas
    Hockessin, DE 19707 (US)

(74) Representative: Murgitroyd & Company 
Scotland House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
WO-A1-94/24888
US-A1- 2003 206 978
US-A1- 2009 028 943
 US-A1- 2003 032 640
US-A1- 2005 147 673
   
  • Gibb, R.C., Rowe, R.C., York, P., Stott, P.W.: "The effect of relative particle size and deformation behaviour on the consolidation of binary powder mixtures", Astra Zeneca INTERNET ARTICLE, 18 July 2007 (2007-07-18), XP002720315, Retrieved from the Internet: URL:http://www.intelligensys.co.uk/sim/ext ras/BPC2005.pdf [retrieved on 2014-02-13]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).